熱門資訊> 正文
Vericel预计2025年收入将达到2.76亿美元
2026-01-13 22:10
- Vericel Corporation (VCEL) on Tuesday said that it expects preliminary full-year 2025 revenue of about $276 million, with MACI sales accounting for $239.5 million and Burn Care revenue of $36.5 million.
- The company said fourth-quarter total revenue and MACI revenue grew 23% year on year.
- Vericel expects gross margins of 74% and adjusted EBITDA margins of 26%, with GAAP net income profitability for the second consecutive year.
- Vericel reported a cash and investments position of $200 million with no debt and highlighted record MACI implants, trained surgeons, and continued commercial expansion.
- Consensus for 2025 revenue is $274.11M.
- VCEL +0.54% premarket to $36.79.
- Source: Press Release
More on Vericel
- Vericel: Growth Plans May Have Run Out Of Gas (Rating Downgrade)
- Vericel Corporation 2025 Q3 - Results - Earnings Call Presentation
- Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript
- Vericel outlines 23% MACI revenue growth for H2 2025 while advancing OUS expansion and MACI Ankle clinical study
- Vericel beats top-line and bottom-line estimates; reaffirms FY25 outlook
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。